Table 3.
Inhibitor | IC50 (Ki), µM * | Type of Inhibition | Cell Type | Reference |
---|---|---|---|---|
Flavones and Isoflavones | ||||
Genistein | 10–15 mM (4–15) | competitive | HL60, CHO, RBC | [114,115,171] |
Myricetin | (23) | competitive | HL60, CHO, RBC | [114] |
Quercetin | (8–16) | competitive | HL60, CHO, RBC | [114,171] |
Morin | (105) | competitive | HL60, CHO, RBC | [114] |
Rhamnetin | (20) | competitive | HL60, CHO, RBC | [114] |
Isorhamnetin | (5) | competitive | HL60, CHO, RBC | [114] |
Biochanin A | (17) | competitive | HL60, CHO, RBC | [114] |
Lavendustin and Tyrphostins | ||||
Lavendustin A | (10) | competitive | HL60, CHO, RBC | [114] |
Lavendustin B | (15) | competitive | HL60, CHO, RBC | [114] |
Tyrphostin B44 | (90) | competitive | HL60, CHO, RBC | [114] |
Tyrphostin B46 | (20–45) | competitive | HL60, CHO, RBC | [114,171] |
Tyrphostin B48 | (50) | competitive | HL60, CHO, RBC | [114] |
Tyrphostin B50 | (45) | competitive | HL60, CHO, RBC | [114] |
Tyrphostin B56 | (170) | competitive | HL60, CHO, RBC | [114] |
Tyrphostin AG879 | (85) | competitive | HL60, CHO, RBC | [114] |
Tyrphostin A47 | (115–160) | noncompetitive | HL60, CHO, RBC | [114,171] |
Other Tyrosine Kinase Inhibitors | ||||
Methyl 2,5- dihydroxycinnamate | (150) | noncompetitive | HL60, CHO, RBC | [114] |
Gossypol | 30 (7) | noncompetitive | HL60, CHO, RBC | [173] |
Methylxanthines | ||||
Pentoxifylline | 4.7 mM (2.8) | uncompetitive | RBC | [55] |
Caffeine | 10 mM (4.5) | uncompetitive | RBC | [55] |
Theophylline | 14.4 mM (5.3) | uncompetitive | RBC | [55] |
Phloretin | 40 | RBC | [55] | |
Other Polyphenols | ||||
Resveratrol | 30 (122) | noncompetitive | HL60, U937, RBC | [116] |
NDGA | 53–85 mM (4.5) | noncompetitive | HL60, U937, RBC | [172] |
Gossypol | 30 (7) | noncompetitive | HL60, CHO, RBC | [173] |
Kaempferol | 4 | mixed | MCF-7 | [174] |
Curcumin | 19 | mixed | L929 | [175] |
* IC50: correspond to 50% of total inhibition in viability experiments; Ki: correspond to inhibition constant in transport experiments.